https://www.cancernetwork.com/view/phillip-h-kuo-md-phd-examines-utility-of-psma-pet-parameters-to-predict-response-to-117lu-psma-617-in-mcrpc
0
0
Phillip H. Kuo, MD, PhD, Examines Utility of PSMA-PET Parameters to Predict Response to 177Lu-PSMA-617 in mCRPC - Cancer Network
8/29/22 at 8:03pm
Organization
Cancernetwork.com
Authors
Phillip H. Kuo MD PhD
47 words
0
Comments
Phillip H. Kuo, MD, PhD, spoke about how prostate-specific membrane antigen PET scan testing affected outcomes in patients with metastatic castration-resistant prostate cancer.
You are the first to view
Create an account or login to join the discussion